Replies to post #330831 on Avid Bioservices Inc (CDMO)

[patientlywaiting]

As I have never posted a "I told you so", I will leave that to one of the others here that expect nothing tomorrow. When we get the activist "company needs to be sold" letter, maybe then.

[jakedogman1]

Agree... the biz is out there ... i don't think they were ready right out of the chute to get some of the biz in that the facilities needed to be upgraded before one could even go after it...

looking forward to the halo update... enhanze is taking off and should really take off by the end of the calendar year for both roche and janssen as they are expected to go into commercialization...

oncologie just raised 80 mil and is planning a trial so we should see some milestones and manuf biz..

[drontle2]

Today's share price action certainly isn't giving us any market conviction for optimism....... :(

[cjgaddy]

What I want more than anything is for new CEO Richard Hancock and CFO Daniel Hart to re-interate the various “profitability is coming” statements from 3-19-19/Q3:

ROGER LIAS (CEO) – OPENING:
“...All of this positions us well for growth and achieving profitability, which we believe is now within reach in the coming FY [FY2020: fye 4-30-20].”

DANIEL HART (CFO) – OPENING:
“...In addition, and importantly, during recent discussions with our customer Halozyme, we were informed that they are planning to increase production levels, which we believe will have a positive impact on our revenue and net income in the coming quarters. ...In the past 12mos, we have significantly diversified our client base, thus reducing risk and building a pipeline of future mfg. Opportunities. ...As a result, we are firmly on track towards profitability and positive EBITDA.”

Q#A #2: Paul Knight - Janney
”You have talked about achieving profitability in FY2020 (fye 4-30-20)...”
Daniel Hart: We're making improvements every day to our business. We'll give more thoughts on the timing of that when we come out with the FY2020 plan.

3-19-19 PR: HIGHLIGHTS SINCE OCTOBER 31, 2018
* “During the past 12mos we have significantly diversified our client base, thus reducing risk and building a pipeline of future mfg. opportunities. We have built commercial and operational infrastructure to support growth, right-sized the organization, significantly cut costs, and increased capacity utilization resulting in improved margins. As a result, we are firmly on-track towards profitability and positive EBITDA."

3-19-19: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147475461

[goodplenty100]

Expecting to hear

Expecting to hear ....Nearing end of negotiations with 2 possibly 3 potential clients (WE CAN NOT DISCLOSE AT THIS TIME) which will fill our already drawn out expanded production facility at near completion.
Well, we can HOPE!